Vimarsana
Biggest News Aggregation in the World

Philogen Spa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philogen Spa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philogen Spa Today - Breaking & Trending Today

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ... - Vimarsana News

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ...

Jaguar Health Appoints European Pharmaceutical Industry Leader as President ...

Philogen reduces loss in 2023; NFP remains positive - Vimarsana News

Philogen reduces loss in 2023; NFP remains positive

The board of directors of Philogen Spa on Wednesday approved the consolidated financial statements as of Dec. 31, 2023, which closed with a loss of EUR6.2 million compared to a net loss of EUR5.4...

Cucinelli on Mib in December; Philogen, d'Amico and SAES on Mid - Vimarsana News

Cucinelli on Mib in December; Philogen, d'Amico and SAES on Mid

Brunello Cucinelli Spa, currently on the Mid-Cap list, will take the place of CNH Industrial NV on the FTSE Italia Mib from Dec. 1, pending CNH Industrial NV's initiation of the delisting confirmed...

European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, ... - Vimarsana News

European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, ...

European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, ...

Jaguar Health, Inc.: European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits - Vimarsana News

Jaguar Health, Inc.: European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits

Dr. Radaelli appointed Interim Executive Director of Napo Therapeutics S.p.A., the corporation established by Jaguar Health in Italy in 2021 that focuses on expanding crofelemer access in EuropeSAN FRANCISCO